Company Auris Medical Holding AG Nasdaq
Equities
CH0408330303
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 03-03-31 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 21-10-31 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Samuel Wickline
CTO | Chief Tech/Sci/R&D Officer | 71 | 21-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 18-02-28 |
Mats Blom
BRD | Director/Board Member | 59 | 17-03-31 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 03-03-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,240,245 | 2,220,245 ( 99.11 %) | 0 | 99.11 % |
Company contact information
Altamira Therapeutics Ltd.
Clarendon House 2 Church Street
HM 11, Hamilton
+441 295 5950
http://www.altamiratherapeutics.com![address Auris Medical Holding AG](https://cdn.zonebourse.com/static/address/42413848.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+16.49% | 122B | |
+20.51% | 116B | |
+22.04% | 27.03B | |
-21.03% | 20.36B | |
-16.89% | 16.43B | |
-18.22% | 15.91B | |
-44.74% | 15.6B | |
+62.58% | 14.94B | |
+2.22% | 13.59B |